Intradermal and subcutaneous leiomyosarcoma: A clinicopathological and immunohistochemical study of 41 cases

Journal of Cutaneous Pathology

Volumn 23, Issue 5, 1996, Pages 458-463

  Jensen, Marianne Lidang ^a,b   Jensen, Olaf Myhre ^a   Michalski, Wojchiech ^a   Nielsen, Ole Steen ^a   Keller, Johnny ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University Institute of Pathology Arhus   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; MUSCLE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DERMIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG; LEIOMYOSARCOMA; LUNG METASTASIS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TUMOR; SUBCUTANEOUS TISSUE TUMOR; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0029992673     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01435.x     Document Type: Article

References (17)

1. Enzinger FM, Weiss SW. Soft tissue tumours. In: Soft tissue tumours. Washington D. C.: C. V.Company, 1995: 503.
2. Fields JP, Helwig EB. Leiomyosarcoma of the skin and subcutaneous tissue. Cancer 1981: 47: 156.
3. Dahl I, Angervall L. Cutaneous and subcutaneous leiomyosarcoma. A clinicopathologic study of 47 patients. Path Europ 1974: 9: 307.
4. Swanson PE, Stanley MW, Scheithauer BW, Wick MR. Primary cutaneous leiomyosarcoma. A histological and immunohistochemical study of 9 cases, with ultrastructural correlation. J Cutan Pathol 1988: 15: 129.
5. Myhre Jensen O, Høgh J, Østgaard SE, Nordentoft AM, Sneppen O. Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases. J Pathol 1991: 163: 19.
6. Boenisch T. Immunohistochemical staining methods. California: DAKO, 1989: 13.
7. Kaplan KL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Soc C 1958: 53: 457.
8. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1965: 50: 163.
9. Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc B 1972: 34: 178.
10. Bentzen SM, Poulsen HS, Kaae S, et al. Prognostic factors in osteosarcomas. A regression analysis. Cancer 1988: 62: 194.
11. Oliver GF, Reiman HM, Gonchoroff NJ, Muller SA, Umbert IJ. Cutaneous and subcutaneous leiomyosarcoma: a clinicopathological review of 14 cases with reference to antidesmin staining and nuclear DNA patterns studied by flow cytometry. Br J Dermatol 1991: 124: 252.
12. Hashimoto H, Daimaru Y, Tsuneyoshi M, Enjoji M. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study. Cancer 1986: 57: 2077.
13. Goldblum JR. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Arch Pathol Lab Med 1995: 119: 238.
14. Kindblom L-G, Lodding P, Rosengren L, Baudier J, Haglid K. S-100 protein in melanocytic tumours. Acta Pathol Microbiol Immunol Scand 1984: 92: 219.
15. Cassidy M, Loftus B, Whelan A, et al. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Virchows Arch 1994: 424: 635.
16. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989: 63: 1607.
17. Slout AP, Hill WT. Leiomyosarcoma of superficial soft tissues. Cancer 1958: 11: 844.